July 22, 2024

Prefilled Syringes Market, Overview, key trends, Key Takeaways

Market Overview

Prefilled syringes eliminate multiple steps related to drawing and mixing of drugs and provide accurate dosing. In addition, these syringes help prevent contamination and reduce dosing errors.

Market key trends

One of the key trends in the prefilled syringes market is the rising demand for self-administration and home healthcare devices. Prefilled syringes enable self-administration of injections by patients suffering from chronic diseases. The risk of infection is also low as these syringes are sterile. Furthermore, prefilled syringes improve patient compliance compared to vials as they provide accuracy and reproducibility of dose. They also minimize over- and under-dosing that are often associated with manual filling of syringes from vials.

Segment Analysis
The global prefilled syringes market is segmented on the basis of material, design, application and end user. By material, the market is dominated by glass prefilled syringes segment due to advantages such as chemical inertness, dimensional stability and transparency. By design, the market is dominated by single-chamber prefilled syringes segment as these syringes are simpler in design and less costly as compared to other designs.

Key Takeaways

The Global Prefilled Syringes Market is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing demand for injectable drugs and rising adoption of self-injection devices.

Regional analysis:
North America dominates the global prefilled syringes market due to favorable reimbursement policies and supportive government initiatives for self-injectable drug delivery in the region.

Key players:

Key players operating in the prefilled syringes market are Gerresheimer AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, Stevanato Group S.p.A.

Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it